Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	5-diphosphoinositol pentakisphosphate 1-kinase activity	PPIP5K1 PPIP5K2	1.39e-05	2	75	2	GO:0033857
GeneOntologyMolecularFunction	inositol hexakisphosphate 3-kinase activity	PPIP5K1 PPIP5K2	8.31e-05	4	75	2	GO:0052724
GeneOntologyMolecularFunction	inositol hexakisphosphate 1-kinase activity	PPIP5K1 PPIP5K2	8.31e-05	4	75	2	GO:0052723
GeneOntologyMolecularFunction	inositol hexakisphosphate 5-kinase activity	PPIP5K1 PPIP5K2	1.38e-04	5	75	2	GO:0000832
GeneOntologyMolecularFunction	diphosphoinositol pentakisphosphate kinase activity	PPIP5K1 PPIP5K2	1.38e-04	5	75	2	GO:0000829
GeneOntologyMolecularFunction	inositol hexakisphosphate kinase activity	PPIP5K1 PPIP5K2	1.38e-04	5	75	2	GO:0000828
GeneOntologyMolecularFunction	inositol-1,3,4,5,6-pentakisphosphate kinase activity	PPIP5K1 PPIP5K2	1.38e-04	5	75	2	GO:0000827
GeneOntologyMolecularFunction	phosphotransferase activity, phosphate group as acceptor	MAGI3 PPIP5K1 PPIP5K2	4.90e-04	41	75	3	GO:0016776
GeneOntologyMolecularFunction	inositol phosphate kinase activity	PPIP5K1 PPIP5K2	7.49e-04	11	75	2	GO:0180030
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	AKAP6 CUL5 GRIP1 KMT2C RUVBL1 MED9 STEEP1 NCOA7 NBN PARP9 CHD4 DGCR8	1.22e-03	1160	75	12	GO:0030674
GeneOntologyCellularComponent	site of DNA damage	CUL5 ELOA HUS1 NBN PARP9 CHD4 DGCR8	6.68e-07	137	76	7	GO:0090734
GeneOntologyCellularComponent	spine synapse	GRIP1 GRIA2	1.30e-05	2	76	2	GO:0106033
GeneOntologyCellularComponent	dendritic spine neck	GRIP1 GRIA2	4.62e-04	9	76	2	GO:0044326
GeneOntologyCellularComponent	junctional sarcoplasmic reticulum membrane	AKAP6 RYR1	5.76e-04	10	76	2	GO:0014701
Domain	IRO	IRX3 IRX1 IRX4	1.34e-06	6	77	3	SM00548
Domain	Iroquois_homeo	IRX3 IRX1 IRX4	1.34e-06	6	77	3	IPR003893
Domain	Homeobox_KN	IRX3 IRX1 IRX4	4.39e-05	17	77	3	PF05920
Domain	Homeobox_KN_domain	IRX3 IRX1 IRX4	4.39e-05	17	77	3	IPR008422
Domain	Homez_dom	ZHX3 ZHX1	5.02e-05	3	77	2	IPR024578
Domain	Homez	ZHX3 ZHX1	5.02e-05	3	77	2	PF11569
Domain	Acid_Pase_AS	PPIP5K1 PPIP5K2	2.49e-04	6	77	2	IPR033379
Domain	HIS_ACID_PHOSPHAT_2	PPIP5K1 PPIP5K2	3.48e-04	7	77	2	PS00778
Domain	HIS_ACID_PHOSPHAT_1	PPIP5K1 PPIP5K2	3.48e-04	7	77	2	PS00616
Domain	His_Pase_clade-2	PPIP5K1 PPIP5K2	4.62e-04	8	77	2	IPR000560
Domain	His_Phos_2	PPIP5K1 PPIP5K2	4.62e-04	8	77	2	PF00328
Domain	-	ZHX3 IRX3 IRX1 TTF1 ZHX1 IRX4	1.11e-03	283	77	6	1.10.10.60
Domain	Homeodomain-like	ZHX3 IRX3 IRX1 TTF1 ZHX1 IRX4	2.48e-03	332	77	6	IPR009057
Domain	PDZ	GRIP1 AHNAK MAGI3 RGS3	2.75e-03	141	77	4	PF00595
Domain	Homeobox	ZHX3 IRX3 IRX1 ZHX1 IRX4	2.81e-03	234	77	5	PF00046
Domain	HOMEOBOX_1	ZHX3 IRX3 IRX1 ZHX1 IRX4	2.91e-03	236	77	5	PS00027
Domain	HOX	ZHX3 IRX3 IRX1 ZHX1 IRX4	2.97e-03	237	77	5	SM00389
Domain	His_PPase_superfam	PPIP5K1 PPIP5K2	3.04e-03	20	77	2	IPR029033
Domain	-	PPIP5K1 PPIP5K2	3.04e-03	20	77	2	3.40.50.1240
Domain	HOMEOBOX_2	ZHX3 IRX3 IRX1 ZHX1 IRX4	3.08e-03	239	77	5	PS50071
Domain	Homeobox_dom	ZHX3 IRX3 IRX1 ZHX1 IRX4	3.08e-03	239	77	5	IPR001356
Domain	PDZ	GRIP1 AHNAK MAGI3 RGS3	3.27e-03	148	77	4	SM00228
Domain	-	GRIP1 AHNAK MAGI3 RGS3	3.43e-03	150	77	4	2.30.42.10
Domain	PDZ	GRIP1 AHNAK MAGI3 RGS3	3.52e-03	151	77	4	PS50106
Domain	PDZ	GRIP1 AHNAK MAGI3 RGS3	3.60e-03	152	77	4	IPR001478
Domain	GRAM	GRAMD2A NCOA7	3.67e-03	22	77	2	PF02893
Domain	GRAM	GRAMD2A NCOA7	3.67e-03	22	77	2	IPR004182
Domain	PHD	KMT2C BAZ1B CHD4	3.68e-03	75	77	3	PF00628
Domain	Znf_PHD-finger	KMT2C BAZ1B CHD4	4.26e-03	79	77	3	IPR019787
Domain	DHHC	KMT2C ZDHHC23	4.73e-03	25	77	2	PS50216
Domain	Znf_DHHC_palmitoyltrfase	KMT2C ZDHHC23	4.73e-03	25	77	2	IPR001594
Domain	PHD	KMT2C BAZ1B CHD4	5.93e-03	89	77	3	SM00249
Domain	Znf_PHD	KMT2C BAZ1B CHD4	6.31e-03	91	77	3	IPR001965
Domain	ZF_PHD_2	KMT2C BAZ1B CHD4	7.11e-03	95	77	3	PS50016
Domain	ZF_PHD_1	KMT2C BAZ1B CHD4	7.31e-03	96	77	3	PS01359
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZHX3 ELOA RUVBL1 AHNAK STEEP1 GNL2 BAZ1B NBN RPRD2 CHD4 DGCR8 CWC25 L3MBTL3 SF3B2	2.49e-08	954	78	14	36373674
Pubmed	Comparison of Iroquois gene expression in limbs/fins of vertebrate embryos.	IRX3 IRX1 IRX4	2.16e-07	6	78	3	20408909
Pubmed	Iroquois homeobox 3 regulates odontoblast proliferation and differentiation mediated by Wnt5a expression.	IRX3 IRX1 IRX4	2.16e-07	6	78	3	36773339
Pubmed	Organization of mouse Iroquois homeobox genes in two clusters suggests a conserved regulation and function in vertebrate development.	IRX3 IRX1 IRX4	2.16e-07	6	78	3	11042145
Pubmed	Regulated expression patterns of IRX-2, an Iroquois-class homeobox gene, in the human breast.	IRX3 IRX1 IRX4	2.16e-07	6	78	3	10370142
Pubmed	The prepattern transcription factor Irx3 directs nephron segment identity.	IRX3 IRX1 IRX4	3.77e-07	7	78	3	17875669
Pubmed	Nucleolar proteome dynamics.	ELOA RUVBL1 GNL2 BAZ1B EXOSC8 CHD4 SF3B2 DYNC1H1 CCNB1	4.30e-07	419	78	9	15635413
Pubmed	Sensitive nonradioactive detection of mRNA in tissue sections: novel application of the whole-mount in situ hybridization protocol.	IRX3 IRX1 IRX4	6.03e-07	8	78	3	11118473
Pubmed	The Iroquois homeobox gene Irx2 is not essential for normal development of the heart and midbrain-hindbrain boundary in mice.	IRX3 IRX1 IRX4	9.03e-07	9	78	3	14585979
Pubmed	Gene and cluster-specific expression of the Iroquois family members during mouse development.	IRX3 IRX1 IRX4	9.03e-07	9	78	3	11520674
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	ZHX3 ELOA STEEP1 GNL2 RPRD2 CHD4 L3MBTL3 SF3B2	9.72e-07	339	78	8	30415952
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	KMT2C RUVBL1 POLR3E MED9 AHNAK STEEP1 BAZ1B NBN RPRD2 CHD4 TTF1 L3MBTL3 ESCO1 SF3B2	1.00e-06	1294	78	14	30804502
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	ELOA STEEP1 GNL2 BAZ1B CHD4 TTF1	1.07e-06	148	78	6	32538781
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ZHX3 ELOA RUVBL1 AHNAK STEEP1 GNL2 BAZ1B NCOA7 NBN RPRD2 CHD4 SF3B2	1.12e-06	934	78	12	33916271
Pubmed	Patterning the embryonic heart: identification of five mouse Iroquois homeobox genes in the developing heart.	IRX3 IRX1 IRX4	1.77e-06	11	78	3	10926765
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	ZHX3 RUVBL1 MYO1D BAIAP2L1 STEEP1 RPRD2 CHD4 SF3B2 DYNC1H1	2.04e-06	506	78	9	30890647
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	AHNAK STEEP1 GNL2 NBN RPRD2 CHD4 SF3B2	2.66e-06	271	78	7	32433965
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	ELOA RUVBL1 STEEP1 GNL2 BAZ1B RPRD2 SF3B2	3.54e-06	283	78	7	30585729
Pubmed	Direct binding of CoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex.	RUVBL1 AHNAK BAZ1B NBN CHD4	4.23e-06	106	78	5	19394292
Pubmed	Imaging-based assays for investigating functions of the RNA polymerase II elongation factor Elongin and the Elongin ubiquitin ligase.	CUL5 ELOA	4.97e-06	2	78	2	30794906
Pubmed	Structural analysis and detection of biological inositol pyrophosphates reveal that the family of VIP/diphosphoinositol pentakisphosphate kinases are 1/3-kinases.	PPIP5K1 PPIP5K2	4.97e-06	2	78	2	18981179
Pubmed	Purification, sequencing, and molecular identification of a mammalian PP-InsP5 kinase that is activated when cells are exposed to hyperosmotic stress.	PPIP5K1 PPIP5K2	4.97e-06	2	78	2	17702752
Pubmed	Mutagenesis reveals a role for ABP/GRIP binding to GluR2 in synaptic surface accumulation of the AMPA receptor.	GRIP1 GRIA2	4.97e-06	2	78	2	10985351
Pubmed	The Significance of the Bifunctional Kinase/Phosphatase Activities of Diphosphoinositol Pentakisphosphate Kinases (PPIP5Ks) for Coupling Inositol Pyrophosphate Cell Signaling to Cellular Phosphate Homeostasis.	PPIP5K1 PPIP5K2	4.97e-06	2	78	2	28126903
Pubmed	Cloning and characterization of two human VIP1-like inositol hexakisphosphate and diphosphoinositol pentakisphosphate kinases.	PPIP5K1 PPIP5K2	4.97e-06	2	78	2	17690096
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	FSIP2 ZHX3 ELOA STEEP1 GNL2 BAZ1B EXOSC8 CHD4 ZHX1	8.97e-06	608	78	9	36089195
Pubmed	KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.	ELOA AHNAK RPRD2 CHD4 SF3B2	1.15e-05	130	78	5	35545047
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	AHNAK NBN EXOSC8 RPRD2 PARP9 CHD4 SF3B2	1.17e-05	340	78	7	24332808
Pubmed	PPIP5K2 and PCSK1 are Candidate Genetic Contributors to Familial Keratoconus.	PPIP5K1 PPIP5K2	1.49e-05	3	78	2	31852976
Pubmed	PICK1 mediates transient synaptic expression of GluA2-lacking AMPA receptors during glycine-induced AMPA receptor trafficking.	GRIP1 GRIA2	1.49e-05	3	78	2	22915106
Pubmed	GRIP1 regulates synaptic plasticity and learning and memory.	GRIP1 GRIA2	1.49e-05	3	78	2	32948689
Pubmed	The AAA+ ATPase Thorase regulates AMPA receptor-dependent synaptic plasticity and behavior.	GRIP1 GRIA2	1.49e-05	3	78	2	21496646
Pubmed	PIKE-mediated PI3-kinase activity is required for AMPA receptor surface expression.	GRIP1 GRIA2	1.49e-05	3	78	2	21847098
Pubmed	GRIP1 is required for homeostatic regulation of AMPAR trafficking.	GRIP1 GRIA2	1.49e-05	3	78	2	26216979
Pubmed	Expression and prognostic significance of zinc fingers and homeoboxes family members in renal cell carcinoma.	ZHX3 ZHX1	1.49e-05	3	78	2	28152006
Pubmed	Kif3a deletion prevents primary cilia assembly on oligodendrocyte progenitor cells, reduces oligodendrogenesis and impairs fine motor function.	PDGFRA KIF3A	1.49e-05	3	78	2	33368703
Pubmed	Identification of the vertebrate Iroquois homeobox gene family with overlapping expression during early development of the nervous system.	IRX3 IRX1	1.49e-05	3	78	2	9486539
Pubmed	mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope.	AKAP6 RYR1	1.49e-05	3	78	2	11590243
Pubmed	The Hematopoietic TALE-Code Shows Normal Activity of IRX1 in Myeloid Progenitors and Reveals Ectopic Expression of IRX3 and IRX5 in Acute Myeloid Leukemia.	IRX3 IRX1	1.49e-05	3	78	2	35328612
Pubmed	Glial progenitor cells in normal and pathological states.	PDGFRA CXCL2	1.49e-05	3	78	2	9884514
Pubmed	Transmembrane and ubiquitin-like domain-containing protein 1 (Tmub1/HOPS) facilitates surface expression of GluR2-containing AMPA receptors.	GRIP1 GRIA2	1.49e-05	3	78	2	18665261
Pubmed	Gain-of-function glutamate receptor interacting protein 1 variants alter GluA2 recycling and surface distribution in patients with autism.	GRIP1 GRIA2	1.49e-05	3	78	2	21383172
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	GRIP1 STXBP3 RUVBL1 MYO1D BAIAP2L1 HUS1 MAGI3 NBN PPIP5K2 DYNC1H1	2.09e-05	853	78	10	28718761
Pubmed	Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.	STEEP1 BAZ1B CHD4 SF3B2	2.14e-05	72	78	4	31248990
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	ZHX3 RUVBL1 BAIAP2L1 MED9 BAZ1B CHD4 MSI1 DYNC1H1	2.64e-05	533	78	8	30554943
Pubmed	Cardiomyopathy in Irx4-deficient mice is preceded by abnormal ventricular gene expression.	IRX3 IRX1 IRX4	2.72e-05	26	78	3	11238910
Pubmed	Cockayne syndrome B protein regulates recruitment of the Elongin A ubiquitin ligase to sites of DNA damage.	CUL5 ELOA	2.97e-05	4	78	2	28292928
Pubmed	The proteoglycan NG2 is complexed with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by the PDZ glutamate receptor interaction protein (GRIP) in glial progenitor cells. Implications for glial-neuronal signaling.	GRIP1 GRIA2	2.97e-05	4	78	2	12458226
Pubmed	Evidence that GRIP, a PDZ-domain protein which is expressed in the embryonic forebrain, co-activates transcription with DLX homeodomain proteins.	GRIP1 GRIA2	2.97e-05	4	78	2	11675124
Pubmed	GRIP1 interlinks N-cadherin and AMPA receptors at vesicles to promote combined cargo transport into dendrites.	GRIP1 GRIA2	2.97e-05	4	78	2	24639525
Pubmed	Critical role for mouse Hus1 in an S-phase DNA damage cell cycle checkpoint.	HUS1 NBN	2.97e-05	4	78	2	12529385
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	FSIP2 ZHX3 RUVBL1 BAIAP2L1 AHNAK RPRD2 SF3B2	3.26e-05	399	78	7	35987950
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	KMT2C RUVBL1 AHNAK STEEP1 BAZ1B NBN RPRD2 DYNC1H1	3.26e-05	549	78	8	38280479
Pubmed	Isolation and characterization of proteins associated with histone H3 tails in vivo.	KMT2C CHD4 SF3B2	4.22e-05	30	78	3	17403666
Pubmed	Iroquois genes influence proximo-distal morphogenesis during rat lung development.	IRX3 IRX1	4.94e-05	5	78	2	16299054
Pubmed	ZHX proteins regulate podocyte gene expression during the development of nephrotic syndrome.	ZHX3 ZHX1	4.94e-05	5	78	2	17056598
Pubmed	Assembly of the Elongin A Ubiquitin Ligase Is Regulated by Genotoxic and Other Stresses.	CUL5 ELOA	4.94e-05	5	78	2	25878247
Pubmed	Expression of two novel mouse Iroquois homeobox genes during neurogenesis.	IRX3 IRX1	4.94e-05	5	78	2	10704856
Pubmed	Expression of Irx6 during mouse morphogenesis.	IRX3 IRX4	4.94e-05	5	78	2	11335133
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	ELOA RUVBL1 GNL2 BAZ1B EXOSC8 CHD4 DGCR8 TTF1 L3MBTL3	5.10e-05	759	78	9	35915203
Pubmed	USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c.	ELOA GNL2 BAZ1B DYNC1H1	5.17e-05	90	78	4	35654790
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	HUS1 MED9 NBN EXOSC8 RPRD2 DGCR8 ZHX1	7.23e-05	453	78	7	29656893
Pubmed	Dual origin of spinal oligodendrocyte progenitors and evidence for the cooperative role of Olig2 and Nkx2.2 in the control of oligodendrocyte differentiation.	PDGFRA IRX3	7.40e-05	6	78	2	11830569
Pubmed	Mouse platelet-derived growth factor receptor alpha gene is deleted in W19H and patch mutations on chromosome 5.	PDGFRA CXCL2	7.40e-05	6	78	2	1647018
Pubmed	Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment.	PIK3CG CXCL2	7.40e-05	6	78	2	20107187
Pubmed	The protein interacting with C-kinase (PICK1) interacts with and attenuates parkin-associated endothelial-like (PAEL) receptor-mediated cell death.	GRIP1 GRIA2	7.40e-05	6	78	2	24749734
Pubmed	Evidence for motoneuron lineage-specific regulation of Olig2 in the vertebrate neural tube.	PDGFRA IRX3	7.40e-05	6	78	2	16469306
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	AKAP6 PPIP5K1 DYNC1H1 ZNF518A	9.08e-05	104	78	4	9205841
Pubmed	PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils.	PIK3CG CXCL2	1.04e-04	7	78	2	18536720
Pubmed	Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking.	GRIP1 GRIA2	1.04e-04	7	78	2	17093100
Pubmed	Ankyrin repeat and suppressors of cytokine signaling box protein asb-9 targets creatine kinase B for degradation.	CUL5 ELOA	1.04e-04	7	78	2	17148442
Pubmed	The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.	ELOA RUVBL1 GNL2 EXOSC8 CHD4 DGCR8 DYNC1H1	1.08e-04	483	78	7	36912080
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYO1D AHNAK GNL2 BAZ1B CHD4 TTF1 SF3B2 DYNC1H1	1.09e-04	653	78	8	22586326
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	ELOA COL17A1 RUVBL1 MYO1D BAIAP2L1 AHNAK GNL2 BAZ1B EXOSC8 SF3B2 DYNC1H1	1.11e-04	1257	78	11	36526897
Pubmed	UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination.	COL17A1 RUVBL1 MYO1D STEEP1 CHD4 SF3B2 DYNC1H1	1.19e-04	491	78	7	36273042
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	CUL5 ZHX3 GNL2 BAZ1B NBN SF3B2	1.21e-04	341	78	6	32971831
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	GRIP1 FSIP2 BAIAP2L1 PDGFRA AHNAK NCOA7 MAGI3 PPIP5K2 ARHGAP19	1.33e-04	861	78	9	36931259
Pubmed	Identification of a novel mouse Iroquois homeobox gene, Irx5, and chromosomal localisation of all members of the mouse Iroquois gene family.	IRX3 IRX1	1.38e-04	8	78	2	10822268
Pubmed	Primary structure and chromosomal localization of human and mouse rod photoreceptor cGMP-gated cation channel.	PDGFRA CXCL2	1.38e-04	8	78	2	1372902
Pubmed	Myosin Va, a Novel Interaction Partner of STXBP1, Is Required to Transport Syntaxin1A to the Plasma Membrane.	MYO1D GRIA2	1.38e-04	8	78	2	37315734
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	AKAP6 ZHX3 KMT2C RPRD2 ZNF518A	1.56e-04	225	78	5	12168954
Pubmed	A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells.	RUVBL1 STEEP1 GNL2 BAZ1B	1.63e-04	121	78	4	22412018
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	FSIP2 RUVBL1 CCDC168 TTF1	1.74e-04	123	78	4	26912792
Pubmed	Analysis of zinc-fingers and homeoboxes (ZHX)-1-interacting proteins: molecular cloning and characterization of a member of the ZHX family, ZHX3.	ZHX3 ZHX1	1.77e-04	9	78	2	12659632
Pubmed	Chromosome mapping of the rod photoreceptor cGMP phosphodiesterase beta-subunit gene in mouse and human: tight linkage to the Huntington disease region (4p16.3).	PDGFRA CXCL2	1.77e-04	9	78	2	1315306
Pubmed	The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation.	L3MBTL3 CCNB1	1.77e-04	9	78	2	22157815
Pubmed	Role and regulation of PDGFRα signaling in liver development and regeneration.	PDGFRA PIK3CG	1.77e-04	9	78	2	23529017
Pubmed	EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.	RUVBL1 MAGI3 CHD4 DYNC1H1	2.02e-04	128	78	4	23858473
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	GRIP1 RUVBL1 MYO1D STEEP1 GNL2 EXOSC8 SF3B2 KIF3A	2.19e-04	723	78	8	34133714
Pubmed	Single-Cell Lineage Tracing Reveals that Oriented Cell Division Contributes to Trabecular Morphogenesis and Regional Specification.	IRX3 IRX4	2.21e-04	10	78	2	27052172
Pubmed	Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS.	PDGFRA FAM136A	2.21e-04	10	78	2	19515974
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	ELOA RUVBL1 AHNAK GNL2 CHD4 MSI1 ARHGAP19	2.31e-04	547	78	7	37267103
Pubmed	Proteomic analysis of DZIP3 interactome and its role in proliferation and metastasis in gastric cancer cells.	RUVBL1 CHD4 CCNB1	2.34e-04	53	78	3	36841324
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ELOA STXBP3 GNL2 NBN RPRD2 PPIP5K2 CWC25 SF3B2	2.40e-04	733	78	8	34672954
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	KMT2C MAGEB4 AHNAK MAGI3 SLC28A3 ESCO1 DYNC1H1 RYR1	2.46e-04	736	78	8	29676528
Pubmed	Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.	GRIP1 FSIP2 RUVBL1 AHNAK PLPPR3 DGCR8 DYNC1H1	2.60e-04	558	78	7	35063084
Pubmed	Combinatorial actions of patterning and HLH transcription factors in the spatiotemporal control of neurogenesis and gliogenesis in the developing spinal cord.	PDGFRA IRX3	2.70e-04	11	78	2	17344230
Pubmed	The RSF1 histone-remodelling factor facilitates DNA double-strand break repair by recruiting centromeric and Fanconi Anaemia proteins.	BAZ1B NBN	2.70e-04	11	78	2	24800743
Pubmed	Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression.	CHD4 CWC25 TTF1	2.76e-04	56	78	3	26919559
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	RUVBL1 AHNAK STEEP1 SF3B2 DYNC1H1	2.83e-04	256	78	5	33397691
Interaction	H2BC21 interactions	CUL5 RUVBL1 MED9 AHNAK BAZ1B NBN MTBP RPRD2 PARP9 CHD4 TTF1 L3MBTL3 ESCO1 DYNC1H1 VWA5B1	4.93e-08	696	77	15	int:H2BC21
Interaction	H3C1 interactions	GRIP1 ELOA KMT2C WDR87 AHNAK STEEP1 GNL2 BAZ1B NBN CHD4 L3MBTL3 ESCO1 SF3B2 DYNC1H1	7.00e-06	901	77	14	int:H3C1
Interaction	SMC5 interactions	ZHX3 ELOA RUVBL1 AHNAK STEEP1 GNL2 BAZ1B NBN RPRD2 CHD4 DGCR8 CWC25 L3MBTL3 SF3B2	2.26e-05	1000	77	14	int:SMC5
Interaction	H3-3A interactions	ZHX3 ELOA KMT2C RUVBL1 PDGFRA STEEP1 GNL2 BAZ1B EXOSC8 CHD4 ZHX1 SF3B2	2.55e-05	749	77	12	int:H3-3A
Cytoband	5p15.3	IRX1 IRX4	1.27e-04	10	78	2	5p15.3
Cytoband	10q24.1	ZNF518A ARHGAP19	6.44e-04	22	78	2	10q24.1
Cytoband	3q21	RUVBL1 PARP9	7.68e-04	24	78	2	3q21
Cytoband	1p36.12	PLA2G2D VWA5B1	2.03e-03	39	78	2	1p36.12
GeneFamily	TALE class homeoboxes and pseudogenes	IRX3 IRX1 IRX4	6.96e-05	26	56	3	526
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZHX3 ZHX1	9.64e-04	15	56	2	529
GeneFamily	PDZ domain containing	GRIP1 AHNAK MAGI3 RGS3	1.26e-03	152	56	4	1220
GeneFamily	PHD finger proteins	KMT2C BAZ1B CHD4	2.73e-03	90	56	3	88
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRIP1 GRAMD2A MYO1D BAIAP2L1 MAGI3 IRX1	9.24e-07	186	78	6	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	LPS_only-Epithelial_alveolar-AT_1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRIP1 GRAMD2A BAIAP2L1 MAGI3 IRX3 IRX1	9.53e-07	187	78	6	ff26a533d310126521efe1d05cf8b9d32e524550
ToppCell	facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1D HUS1 FAM136A NCOA7 ZHX1	1.03e-05	164	78	5	1d0d88132baaa3154c3e6e4ef0aff795afab08a2
ToppCell	facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1D HUS1 FAM136A NCOA7 ZHX1	1.03e-05	164	78	5	bd2e10b015d5e6a338675500ec5d81dc39583b3e
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRIP1 GRAMD2A BAIAP2L1 MAGI3 IRX1	1.57e-05	179	78	5	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRIP1 GRAMD2A MYO1D BAIAP2L1 MAGI3	1.66e-05	181	78	5	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRIP1 GRAMD2A BAIAP2L1 IRX3 IRX1	1.75e-05	183	78	5	274483009b309289e4cb84beedf6806430db6ff6
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRIP1 GRAMD2A BAIAP2L1 IRX3 IRX1	1.84e-05	185	78	5	3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRIP1 GRAMD2A BAIAP2L1 MAGI3 IRX1	1.84e-05	185	78	5	c82eab551f65ecebe6db908eda9f9eb3414693c7
ToppCell	Mesenchymal_cells-Adipo-CAR\|World / Lineage and Cell class	TGFBR3 PDGFRA SERPING1 IRX3 RGS3	1.89e-05	186	78	5	6ca8ce7ced91d6308b7c056032ffec1b37c974bf
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	GRIP1 TACR3 IRX3 IRX1 CCNB1	2.15e-05	191	78	5	39220f4a345e328f7fa4fd462a0abeea821b3e02
ToppCell	PND03-Epithelial\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GRAMD2A BAIAP2L1 MAGI3 IRX3 IRX1	2.20e-05	192	78	5	d8c23693f690d4d568585537bbfedda05d505b3d
ToppCell	Epithelial\|World / shred on cell class and cell subclass (v4)	GRAMD2A BAIAP2L1 MAGI3 IRX3 IRX1	2.20e-05	192	78	5	13a3553d9a7c78535679d23d454c63fd08f7d218
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TGFBR3 PDGFRA PTPRS SERPING1 CXCL2	2.37e-05	195	78	5	fc43cd295f2cc3f6e9442232e028944f011c82cc
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TGFBR3 PDGFRA PTPRS SERPING1 CXCL2	2.49e-05	197	78	5	ab5d3ebc73bd7cfc64381d14b92878b370205186
ToppCell	5'-Adult-Appendix-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TGFBR3 PDGFRA PTPRS SERPING1 CXCL2	2.49e-05	197	78	5	b11a5d909942a4299cbc0b27332b1a3f66f3bccd
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RUVBL1 PDGFRA PTPRS GRIA2 CCNB1	2.55e-05	198	78	5	039b67ddd0ac529453a364552abca04e67d8417c
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	KMT2C AHNAK SERPING1 PARP9 DYNC1H1	2.55e-05	198	78	5	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RUVBL1 PDGFRA PTPRS GRIA2 CCNB1	2.55e-05	198	78	5	a07307ecc3d86fbcaf7369b7fce60334b7e2dc8f
ToppCell	Nasal_Brush-Epithelial-Goblet_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	IL32 SERPING1 NCOA7 SLC28A3 CXCL2	2.61e-05	199	78	5	aa6f1390283617c7f9aaf91d379024832ea24a9e
ToppCell	Nasal_Brush-Epithelial-Goblet_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	IL32 SERPING1 NCOA7 SLC28A3 CXCL2	2.61e-05	199	78	5	2ac716f887687b5109fb9feced75d5c62646a268
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KMT2C AHNAK SERPING1 PARP9 DYNC1H1	2.68e-05	200	78	5	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Sepsis-Leuk-UTI\|Sepsis / Disease, condition lineage and cell class	GRIP1 IL32 PTPRS LRRC69 SERPING1	2.68e-05	200	78	5	7d92b24c0c888dd46e40b7e3c6c2645c3604f132
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRAMD2A MYO1D BAIAP2L1 MAGI3	8.04e-05	130	78	4	6434d9106ccb38786dad36fab80163dfc07b6eb7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GRIP1 TDRD15 ZHX1 VWA5B1	1.07e-04	140	78	4	e64f6aa57bc069cfe970089bd1c298433bfaf771
ToppCell	Epithelial-B_(AT1-AT2-progenitors)\|World / shred on cell class and cell subclass (v4)	GRAMD2A MAGI3 IRX3 IRX1	1.26e-04	146	78	4	4511916904c1fac252cb68e871b782207f8137b3
ToppCell	facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRS AHNAK LRRC69 TACR3	1.29e-04	147	78	4	9d7e965fe61bd7b31e09c4b2129a5a98c36f4811
ToppCell	facs-Marrow-B-cells-24m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRS AHNAK LRRC69 TACR3	1.29e-04	147	78	4	38552953ff65a0fc20bee6ef57dc5885306ad18b
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	ELOA CHD4 CCDC168 ZNF518A	1.36e-04	149	78	4	768877bade04ca0321593b8470b5011ad8270431
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PDGFRA SERPING1 DGCR8 MSI1	1.55e-04	154	78	4	44d4d99b08216c0901e3bc32743fa0a8b85b5149
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	TGFBR3 TACR3 IRX3 IRX4	1.55e-04	154	78	4	df1b58a20af73fa79c6c069c0117a9ffd85b476f
ToppCell	facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLA2G2D AHNAK TACR3 RYR1	1.62e-04	156	78	4	2ba838bc864c2c1767bcab7bb4d790af96b91387
ToppCell	BAL-Mild-cDC_5\|Mild / Compartment, Disease Groups and Clusters	PDE6A PTPRS RYR1 CCNB1	1.83e-04	161	78	4	7a6e8ed0b5d999efce8945d8083ab01d71be9a92
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-CD8_low_T\|T/NK_cells / Location, Cell class and cell subclass	TGFBR3 IL32 PIK3CG AHNAK	1.97e-04	164	78	4	92fb94492fc2b683e9d50a9db6f01d23c194b0e4
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Trm/em_CD8\|GI_small-bowel / Manually curated celltypes from each tissue	TGFBR3 IL32 AHNAK IRX1	2.21e-04	169	78	4	17568e7aacfdcd96c469bae57d5ffad04954e9bd
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	TGFBR3 PDGFRA SERPING1 CXCL2	2.21e-04	169	78	4	84b898a9fd8ced67c6a501d5cef6416f519902c4
ToppCell	3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL32 COL17A1 AHNAK CXCL2	2.31e-04	171	78	4	0de81d12a8000f2c59cdb214e67dc526d18098fe
ToppCell	3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic-Colonocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL32 COL17A1 AHNAK CXCL2	2.31e-04	171	78	4	0597339618fb4d416d55c538eceb353218a55002
ToppCell	facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL17A1 PTPRS AHNAK RYR1	2.41e-04	173	78	4	ca3d2a9562734f76127e3e7d54c10b63e95141bb
ToppCell	PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GRAMD2A MAGI3 IRX3 IRX1	2.41e-04	173	78	4	45808cf69122c16b9d2b5ffa06d15392c55954b7
ToppCell	facs-Marrow-T-cells-24m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL17A1 PTPRS AHNAK RYR1	2.41e-04	173	78	4	19a9e10885173d7712996be8660a3a5a7a9aa39f
ToppCell	PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GRAMD2A MAGI3 IRX3 IRX1	2.41e-04	173	78	4	7fa9dbcb258c3ab974490063951620e2def03db1
ToppCell	P07-Epithelial\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GRAMD2A BAIAP2L1 IRX3 IRX1	2.41e-04	173	78	4	8b10087a917b825809d35a2b2b349c73a2782472
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO1D ZDHHC23 PIK3CG MAGI3	2.47e-04	174	78	4	bc978a2148a0261a4f9d1ca5479b707e224566be
ToppCell	droplet-Lung-18m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STXBP3 PLA2G2D CXCL2 ARHGAP19	2.47e-04	174	78	4	33e5903adb746f693433bdca11a75c508bbf50c0
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRAMD2A BAIAP2L1 IRX3 IRX1	2.47e-04	174	78	4	d0e3d15731de6c19c232e3aa492c39d8151cf4ed
ToppCell	droplet-Lung-18m-Hematologic-myeloid-interstitial_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STXBP3 PLA2G2D CXCL2 ARHGAP19	2.47e-04	174	78	4	ca0c2f42544092848541863c4a47b334e6828b8a
ToppCell	P07-Epithelial-alveolar_epithelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GRAMD2A BAIAP2L1 IRX3 IRX1	2.47e-04	174	78	4	2739de68e0266054694f99807cfb1f07b6bbb371
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 ZHX3 AHNAK ESCO1	2.58e-04	176	78	4	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	IIH-CD8-antiviral_CD4\|IIH / Condition, Cell_class and T cell subcluster	MED9 STEEP1 PARP9 RGS3	2.63e-04	177	78	4	fe73608c40701eca88b260aeb5c0640d7bee72ba
ToppCell	P15-Epithelial\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GRAMD2A BAIAP2L1 IRX3 IRX1	2.75e-04	179	78	4	869d3d203e2cb88636e2f0c4476c72571ae3b5ca
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRAMD2A MAGI3 IRX3 IRX1	2.75e-04	179	78	4	88dbec952507d84b85b08165eec80df99ed1e736
ToppCell	facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRAMD2A MAGI3 IRX3 IRX1	2.75e-04	179	78	4	daf8189a22786171e2b629261cf720736aa4ebdb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRIP1 NCOA7 MAGI3 VWA5B1	2.75e-04	179	78	4	e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	TGFBR3 TRPM4 MAGI3 DGCR8	2.81e-04	180	78	4	12f3c4c4aa7fe03c0ef847bd4d4942c808015f5f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	TGFBR3 TRPM4 MAGI3 DGCR8	2.81e-04	180	78	4	1bc01bb76d0d3f8db74f9244436d3e6d6015ed5d
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 SLC28A3 IRX3 IRX1	2.81e-04	180	78	4	b798a3fa2dd15b68aa4267f665559527043dcc07
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	TGFBR3 TRPM4 MAGI3 DGCR8	2.81e-04	180	78	4	2a28fbfe10a340c8662c2c8be33792f41fc09088
ToppCell	P03-Epithelial-alveolar_epithelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GRAMD2A BAIAP2L1 IRX3 IRX1	2.87e-04	181	78	4	c3dbf8850d3812fbb770798f4cf38908db8bb92b
ToppCell	P15-Epithelial-alveolar_epithelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GRAMD2A BAIAP2L1 IRX3 IRX1	2.87e-04	181	78	4	7033be0ba90556f7e5f7c0d4a9f7644afcb22c9b
ToppCell	P03-Epithelial\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GRAMD2A BAIAP2L1 IRX3 IRX1	2.87e-04	181	78	4	de0466072f5b2ab8db3d9bab31e3205d1ff7cfb7
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	GRIP1 NCOA7 MAGI3 CXCL2	2.87e-04	181	78	4	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	Control-Epithelial_alveolar-AT_1-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRAMD2A BAIAP2L1 IRX3 IRX1	2.93e-04	182	78	4	a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GRAMD2A AHNAK MAGI3 IRX3	2.93e-04	182	78	4	573771130247e869e4e58f22d4a1cb31989635cf
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRAMD2A BAIAP2L1 IRX3 IRX1	2.93e-04	182	78	4	cc79e0cc21e2fdc4ef77f052818d27b9f707aec1
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 SLC28A3 IRX3 IRX1	2.93e-04	182	78	4	1e2149b222a3e9f64841aed45288a6f29394e7b0
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GRAMD2A AHNAK MAGI3 IRX3	2.93e-04	182	78	4	6cfaa2b3b3974c13b01c943f4adb70768dcc35e4
ToppCell	lymphoid-T_cell-CD8+_Effector_T_cell\|lymphoid / Lineage, cell class and subclass	TGFBR3 IL32 EVC2 RYR1	2.93e-04	182	78	4	d4ef4a7c0f5dc044eb5cc6c0bcf539c88b1b4fef
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	KMT2C NCOA7 PARP9 CXCL2	2.99e-04	183	78	4	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	GRIP1 GRAMD2A MYO1D MAGI3	2.99e-04	183	78	4	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRAMD2A BAIAP2L1 IRX3 IRX1	2.99e-04	183	78	4	06ac66726ec53db810ebb90ec69cfdb903da53f6
ToppCell	COVID-19-kidney-CD-IC-A\|kidney / Disease (COVID-19 only), tissue and cell type	BAIAP2L1 NCOA7 MAGI3 VWA5B1	2.99e-04	183	78	4	5c7597a5b2bf6a481ca2c7e68560179214150fa0
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRIP1 GRAMD2A BAIAP2L1 IRX1	2.99e-04	183	78	4	ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCell	P28-Epithelial\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GRAMD2A BAIAP2L1 IRX3 IRX1	3.05e-04	184	78	4	05811d13bd8a602095a3fcf5e55345edadc7b8bf
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRAMD2A BAIAP2L1 IRX3 IRX1	3.05e-04	184	78	4	7cc5796557379c3d1db078c1aeda40659c6e401c
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHNAK BAZ1B CHD4 CXCL2	3.05e-04	184	78	4	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRAMD2A BAIAP2L1 IRX3 IRX1	3.05e-04	184	78	4	cdf6f1c6cce97a7effa0c55959652e2c0b6992b3
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AHNAK IRX3 MSI1 CXCL2	3.05e-04	184	78	4	22c18964818fc9c8f18051f836d718937b0d8d12
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1-AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRAMD2A BAIAP2L1 IRX3 IRX1	3.11e-04	185	78	4	68f428e169cfb77de970bdfdeea9b9f16f68d2ba
ToppCell	PND01-03-samps-Epithelial\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	GRAMD2A BAIAP2L1 IRX3 IRX1	3.11e-04	185	78	4	2b854df79cfe2cb4d2f9c2938a066e0aa3649325
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRAMD2A BAIAP2L1 IRX3 IRX1	3.11e-04	185	78	4	0c247a3f394c42e2a6f67fee3d9cf33096fecd13
ToppCell	P28-Epithelial-alveolar_epithelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GRAMD2A BAIAP2L1 IRX3 IRX1	3.11e-04	185	78	4	5bb513e569f3a197d55ae2ca683e202daebabeac
ToppCell	Mesenchymal_cells-Osteo-CAR\|World / Lineage and Cell class	TGFBR3 SERPING1 IRX3 RGS3	3.11e-04	185	78	4	16f1588893d09c864e0cb4f837a1b972a1a57baa
ToppCell	21-Trachea-Epithelial-Goblet-like_secretory\|Trachea / Age, Tissue, Lineage and Cell class	TRPM4 NCOA7 IRX3 CXCL2	3.18e-04	186	78	4	f8cddad28896f0edf10a8645fa49a011b22b120d
ToppCell	PND03\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GRAMD2A AHNAK MAGI3 CXCL2	3.24e-04	187	78	4	b3fcb36d853adfdea7172c5591de06f027e50af3
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRAMD2A BAIAP2L1 IRX3 IRX1	3.24e-04	187	78	4	201ff693e4756ee3e44762885b3a303a77eb535b
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma\|TCGA-Prostate / Sample_Type by Project: Shred V9	TRPM4 BAIAP2L1 GNL2 MSI1	3.24e-04	187	78	4	fa0452f3382c22c0391b241d06504fda3c6a19f0
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRAMD2A MYO1D BAIAP2L1 MAGI3	3.24e-04	187	78	4	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	TCGA-Prostate-Primary_Tumor\|TCGA-Prostate / Sample_Type by Project: Shred V9	TRPM4 BAIAP2L1 GNL2 MSI1	3.24e-04	187	78	4	3e6a95c912dad5d61e10497ffaafd2b9027cd13a
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AKAP6 COL17A1 GRIA2 CCDC168	3.31e-04	188	78	4	e239bcdbd210a398a5850cb6fbf171d402f45a4f
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRAMD2A BAIAP2L1 IRX3 IRX1	3.31e-04	188	78	4	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PDGFRA SERPING1 IRX3 RGS3	3.31e-04	188	78	4	de6f4889e0c5f39fbbaefd85526f645c6afa09d5
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_early\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MCHR2 IRX3 IRX1 CCNB1	3.38e-04	189	78	4	a6c62b456982067ad4d224a2efa3919969000693
ToppCell	droplet-Fat-SCAT-30m\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBR3 AHNAK SERPING1 IRX1	3.38e-04	189	78	4	8161910a19089f8cc5a3f1fda039f41a2488f04f
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRAMD2A BAIAP2L1 IRX3 IRX1	3.38e-04	189	78	4	5f883ef4cc0383142d538ae61f4fb40dfdb8ef18
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TGFBR3 PDGFRA PTPRS SERPING1	3.38e-04	189	78	4	d531399749409d614adca13d181830c6e3287508
ToppCell	ASK428-Epithelial-Transformed_epithelium\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	AKAP6 EVC2 PDGFRA SERPING1	3.38e-04	189	78	4	87189275234b5d59484c58acbb14a09903f2b578
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	TGFBR3 PDGFRA PTPRS SERPING1	3.38e-04	189	78	4	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	droplet-Fat-SCAT\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBR3 AHNAK SERPING1 IRX1	3.38e-04	189	78	4	264c59de2adb8bee5bb57633d79d530a8829617b
ToppCell	PND10-Epithelial\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GRAMD2A BAIAP2L1 IRX3 IRX1	3.38e-04	189	78	4	89349e226a5512833a94b1bf68056a6985fe4afd
Drug	AG-012559 [369370-06-9]; Up 200; 10uM; PC3; HT_HG-U133A	TGFBR3 ELOA PDGFRA LONP2 STEEP1 NBN CXCL2	4.48e-06	193	78	7	6920_UP
Disease	Medulloblastoma	PDGFRA PIK3CG NBN L3MBTL3	8.11e-06	50	75	4	C0025149
Disease	Childhood Medulloblastoma	PDGFRA PIK3CG L3MBTL3	1.81e-04	43	75	3	C0278510
Disease	Melanotic medulloblastoma	PDGFRA PIK3CG L3MBTL3	1.81e-04	43	75	3	C1275668
Disease	Medullomyoblastoma	PDGFRA PIK3CG L3MBTL3	1.81e-04	43	75	3	C0205833
Disease	Desmoplastic Medulloblastoma	PDGFRA PIK3CG L3MBTL3	1.81e-04	43	75	3	C0751291
Disease	Adult Medulloblastoma	PDGFRA PIK3CG L3MBTL3	1.81e-04	43	75	3	C0278876
Disease	rectum cancer (is_implicated_in)	NBN CHD4	2.27e-04	9	75	2	DOID:1993 (is_implicated_in)
Disease	prostate adenocarcinoma (is_marker_for)	PDGFRA CCNB1	2.83e-04	10	75	2	DOID:2526 (is_marker_for)
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	TDRD15 ZHX3 BAZ1B	3.01e-04	51	75	3	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	Abruptio Placentae	TDRD15 IRX1	4.14e-04	12	75	2	EFO_1001754
Disease	migraine disorder, type 2 diabetes mellitus	ZHX3 NCOA7 SLC28A3	4.86e-04	60	75	3	MONDO_0005148, MONDO_0005277
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	TDRD15 ZHX3 BAZ1B	7.33e-04	69	75	3	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	Lung diseases	PDGFRA IRX3 IRX1	1.05e-03	78	75	3	C0024115
Disease	Hypertriglyceridemia	TDRD15 BAZ1B	1.06e-03	19	75	2	EFO_0004211
Disease	basophil percentage of granulocytes	GRIP1 CXCL2 RYR1	1.25e-03	83	75	3	EFO_0007995
Disease	in situ carcinoma (is_marker_for)	PDGFRA CCNB1	1.30e-03	21	75	2	DOID:8719 (is_marker_for)
Disease	acute necrotizing pancreatitis (biomarker_via_orthology)	SERPING1 CXCL2	1.99e-03	26	75	2	DOID:0080998 (biomarker_via_orthology)
Disease	RS-10-hydroxywarfarin measurement	BAIAP2L1 PIK3CG IRX1	2.02e-03	98	75	3	EFO_0803330
Disease	Sezary Syndrome	KMT2C IL32	2.15e-03	27	75	2	C0036920

Protein segments in the cluster

Peptide	Gene	Start	Entry
KMMEKKGTKIQTPAA	TTF1	841	Q15361
NTPAKKEMELLIMTK	COL17A1	351	Q9UMD9
ILKNMFLPQKKMIKE	CUL5	741	Q93034
NPVKMKKIKELLQMS	CWC25	156	Q9NXE8
KGLKTPKTKMKQMTL	BAZ1B	426	Q9UIG0
PKTKMKQMTLLDMAK	BAZ1B	431	Q9UIG0
KLKMPEMNIKAPKIS	AHNAK	2566	Q09666
KFKMPEMNIKAPKIS	AHNAK	3206	Q09666
KFKMPEMNIKAPKIS	AHNAK	4446	Q09666
VQPMMTKIKTVLKSR	DGCR8	281	Q8WYQ5
VITPKMLMSFVLKKN	OR8B8	76	Q15620
LGKKSRLMKTVQTMK	RGS3	506	P49796
EVKKLMDEVIKSMKP	EXOSC8	261	Q96B26
TKGEKIMLAIITKMT	IRX4	171	P78413
KKKMMEEKLHRQPVS	PARP9	686	Q8IXQ6
QKKMKLEVVDKRNPM	L3MBTL3	476	Q96JM7
TKIITLNGKKMTKMP	LRRC69	16	Q6ZNQ3
SRSQPVMKVAVKMLK	PDGFRA	616	P16234
VMKVAVKMLKPTARS	PDGFRA	621	P16234
TVMKDPYKVVMKQSK	GNL2	101	Q13823
AITDPIMKAKMVALK	KMT2C	3091	Q8NEZ4
VKEIKRLKKMPQSMP	LONP2	291	Q86WA8
MKEPTTKAEMLKIIS	MAGEB4	126	O15481
KKIKRMVEKSLPSKM	MAGI3	1356	Q5TCQ9
KNEKEMKIKMTAPVT	HEBP2	76	Q9Y5Z4
KPDVSKQGSKMLTKM	FSIP2	6866	Q5CZC0
FMSLGISIMIKKPQK	GRIA2	516	P42262
MIKNVLSMPIVNKKE	PDE6A	381	P16499
MKLDKKMEVFIPLST	EVC2	101	Q86UK5
KKKVSPDKMIEMQAK	KIF3A	411	Q9Y496
VIAPKMLMNFLVKKK	OR8J3	76	Q8NGG0
NKMVECKKAQPKEVM	MSI1	176	O43347
KSKFQEMRKLISTMP	MED9	91	Q9NWA0
SPKNFKVKMIMKTSV	PTPRS	1036	Q13332
VPKQRVMKLTKMVLV	MCHR2	241	Q969V1
KVSEQLQAKMPMKKE	CCNB1	51	P14635
MKKLKARMVMLLPTS	IL32	11	P24001
LNMMKKQKVKTIFPH	BAIAP2L1	336	Q9UHR4
LNPASPMVKKIIEKM	CXCL2	86	P19875
PMVKKIIEKMLKNGK	CXCL2	91	P19875
TVKKIAPMMAKTIKA	ELOA	776	Q14241
KNSVIKVPMMNSKKY	SERPING1	316	P05155
LALMKKVSKSPLVMD	DYNC1H1	1576	Q14204
MATSVVPKKNEMKKS	ESCO1	251	Q5FWF5
LIPTMTKKMKEALLS	FAM136A	121	Q96C01
VKAMDMKRIKSPNII	CCDC168	3666	Q8NDH2
KMKQEIKEIMSPTPV	GRIP1	986	Q9Y3R0
VIPVVSVQMIKKHKM	GRAMD2A	126	Q8IUY3
AKNPKIAVSKMMMVL	CHD4	191	Q14839
MMNLEKKPAKSILKS	RPRD2	846	Q5VT52
EDNLKKTKLPKTYMM	RYR1	946	P21817
QIKILMKNVKVMPFA	POLR3E	281	Q9NVU0
AVIPKMILRKMDKIK	MTBP	516	Q96DY7
TKGEKIMLAIITKMT	IRX3	156	P78415
QEPPKKVMMTKRTKD	STEEP1	136	Q9H5V9
KMEPVSKNKMKTSLN	TDRD15	1216	B5MCY1
KEKKMVVQKPHGTME	NCOA7	101	Q8NI08
PKEIKVSKMEQKFRM	NBN	381	O60934
TKGEKIMLAIITKMT	IRX1	156	P78414
PVLKTMKSVVEKMKN	HUS1	161	O60921
NPKMELLIPVKKKSM	PDIK1L	286	Q8N165
TEKPKITLKNAMKME	SLC28A3	411	Q9HAS3
LKAKRKVVKMMIIVV	TACR3	291	P29371
MKKMPHFRKQITKQV	STXBP3	331	O00186
NKMVKQVTGKMPILS	PLA2G2D	26	Q9UNK4
SKLKLPMIMKQSQSE	AKAP6	1476	Q13023
KMAKKKSLMDIPESQ	PIK3CG	251	P48736
QKTMKSKMREKVRPK	SF3B2	546	Q13435
MISTKEKNKIPKDSM	PLPPR3	1	Q6T4P5
SKMTPSKNITKKMDK	SYCP2	991	Q9BX26
ISISKTPIMKMMKNK	ZHX1	176	Q9UKY1
MMSEKKKKNPTPESV	ARHGAP19	436	Q14CB8
KTAVLGPTLKNVMMK	ZNF518A	416	Q6AHZ1
ILSMMGQLMKPKKTE	RUVBL1	256	Q9Y265
MTQKGSMKPVKKKKT	ZDHHC23	1	Q8IYP9
MAKKSKSKPMKEILE	PPIP5K2	51	O43314
ITKTPIMKIMKGKAE	ZHX3	181	Q9H4I2
KKLMSTALEMKEKTP	WDR87	2391	Q6ZQQ6
LGPKIVIVSKMMKDV	TRPM4	916	Q8TD43
AMTKKSKSKPMTQIL	PPIP5K1	61	Q6PFW1
MMQNKKTFTKPLAVI	TGFBR3	741	Q03167
LQPKMVKSLKKAMAP	VWA5B1	521	Q5TIE3
KMDPTKQYKVMKTIP	MYO1D	886	O94832